Mixed reality technologies, especially augmented reality applications in medicine are growing dramatically in the last year. In fact two companies recently achieved FDA 510K clearance for clinical use cases. As such it has been even more imperative for clinicians to better understand how these technologies are best utilized in healthcare applications and how important they will be to train the next generation of physicians and physician-innovators. New academic-industry partnerships such as the NSF MIXR and IMMERSIVE centers are leading this charge around how to bridge current technology gaps and increase use and adoption in the clinical environment. I will be discussing several recent applications and use cases I have participated in and lessons learned through my roles at the University of Michigan and the University of Illinois leading some of these efforts.
Speakers
Mark S. Cohen, MD, FSSO, FACS
Dean, Carle Illinois College of Medicine | Senior Vice President and Chief Academic Officer, Carle Health
Dean, Carle Illinois College of Medicine | Senior Vice President and Chief Academic Officer, Carle Health
Mark S. Cohen, MD, FSSO, FACS, is Dean of the Carle Illinois College of Medicine at the University of Illinois Urbana-Champaign and Senior Vice President and Chief Academic Officer of Carle Health. He is also a Professor of Surgery and Biomedical and Translational Sciences in the Carle Illinois College of Medicine and Professor of Bioengineering in the Grainger College of Engineering at the University of Illinois, Urbana-Champaign. Dean Cohen holds a B.S. degree in chemical engineering and M.D. from Washington University in St. Louis. He is board certified by the American Board of Surgery and is a Fellow of the American College of Surgeons and is a Fellow of the Society of Surgical Oncology. He has held several national leadership positions in surgical societies and is a founding member and program co-lead of the Holomedicine Association and currently Chairs the American College of Surgeons’ Committee on Emerging Surgical Technology and Education. Dean Cohen is a practicing Surgical Oncologist treating patients with advanced endocrine malignancies as well as melanomas. He has run an NIH R01-funded translational oncology laboratory for the last 15 years working on developing novel therapeutics and diagnostics for the treatment and staging of advanced cancers as well as new programs in tissue engineering, AI and machine learning in health care decision-making, and use of extended reality technologies in teaching, skills development, and health-care delivery. He developed several educational programs in Innovation and entrepreneurship for medical students, residents, and faculty as well as co-founding five start-up companies to improve the care of surgical patients. He has mentored over 200 faculty, residents, and students on surgical innovation projects, advised numerous startups and delivered over 100 invited national and international talks, published over 120 original scientific articles, 13 book chapters, as well as a textbook on Innovation and Entrepreneurship in academic medicine.
Moderators
Jonathan Wakim
MD/MBA Candidate Perelman School of Medicine and Wharton School of Business, University of Pennsylvania
MD/MBA Candidate Perelman School of Medicine and Wharton School of Business, University of Pennsylvania
Jonathan Wakim is an MD/MBA candidate at the Perelman School of Medicine and the Wharton School at the University of Pennsylvania. He graduated from the University of Florida with a degree in Economics. He has worked in the Center for Safety, Simulation, and Advanced Learning Technologies developing mixed reality simulators for training physicians and co-led a study employing virtual reality for pain and anxiety relief. He conducts research using mixed reality in the interventional suite and using digital health tools for remote patient monitoring at the Penn Image-Guided Interventions Lab and the Penn Center for Cancer Innovation. He currently serves as the co-president of Penn HealthX and Director of VC for MD+. He has given presentations on XR at ASA, SIR, and IVRHA and has published several papers in the space. Most recently, he has been working in digital health venture capital with LionBird where he is researching and investing in innovative technologies increasing access and quality to care.
